The contents
of this lecture presentation include : Vaccines can prevent viral disease, Why
are there so few antiviral drugs?, Antiviral history, Blind screening, Antiviral
discovery today, The path of drug discovery, Mechanism-based screens, Cell-based
screen, Antiviral screening, High throughput screening, Dangers of drug
resistance, Mechanisms of drug resistance, Acyclovir mechanism of action,
Improving acyclovir, Acyclovir-resistant HSV, Symmetrel, Influenza virus NA
inhibitors, WIN compounds, Inhibitors of picornavirus uncoating, New HCV drugs,
HCV new drug pipeline, Azido-deoxythymidine, AZT, Non-nucleoside RT inhibitors,
IN inhibitors, Maraviroc: CCR5 inhibitor, Combination therapy, Mathematics of
drug resistance, ART saves lives, Pre-exposure prophylaxis.
Author(s): Prof. Vincent Racaniello, Columbia University
This volume evaluates the carcinogenic
risk to humans posed by infections with human immunodeficiency viruses types 1
and 2 (HIV-1 and HIV-2) and human T-cell lymphotropic viruses types I and II (HTLV-I
and HTLV-II).
Author(s): National
Center for Biotechnology Information, U.S
Adenoviruses are a group of common viruses that infect the lining of
your eyes, airways and lungs, intestines, urinary tract, and nervous system. In
this book, the authors highlight the achievements in the study of animal and
human adenoviruses, chemotherapy of adenovirus infections, and the development
in adenoviral vector-based vaccines and gene therapy. This book will be useful
not only for researchers but also in solving specific medical problems.
This note
explains the following topics: Central Nervous System Viruses, Gastrointestinal
Tract Viruses, Immune System versus Viruses, Respiratory Viruses, ViralMichigan
State University
This note explains the following topics: The origin
of virology, Virus structure, Enveloped virus, Genomes, Viral genomes and
classification of viruses.